Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AVEANNA HEALTHCARE HOLDINGS INC.

(AVAH)
  Report
Delayed Nasdaq  -  04:00 2022-09-29 pm EDT
1.560 USD   -5.17%
08/19Barclays Adjusts Price Target on Aveanna Healthcare Holdings to $5 From $7, Reiterates Overweight Rating
MT
08/15Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $6 From $8, Reiterates Strong Buy Rating
MT
08/12Deutsche Bank Adjusts Price Target on Aveanna Healthcare Holdings to $3 From $6, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Aveanna Healthcare Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 02, 2022

08/10/2022 | 07:12pm EDT

Aveanna Healthcare Holdings Inc. reported earnings results for the second quarter and six months ended July 02, 2022. For the second quarter, the company reported sales was USD 442.96 million compared to USD 436.11 million a year ago. Net loss was USD 473.89 million compared to net income of USD 1.26 million a year ago. Basic loss per share from continuing operations was USD 2.56 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 2.56 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.
For the six months, sales was USD 893.49 million compared to USD 853.27 million a year ago. Net loss was USD 448.55 million compared to net income of USD 7.06 million a year ago. Basic loss per share from continuing operations was USD 2.43 compared to basic earnings per share from continuing operations of USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 2.43 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.


© S&P Capital IQ 2022
Stocks mentioned in the article
ChangeLast1st jan.
AVEANNA HEALTHCARE HOLDINGS INC. -5.17% 1.56 Delayed Quote.-78.92%
PAX DOLLAR (USDP/USD) -0.20% 0.999 End-of-day quote.-0.09%
All news about AVEANNA HEALTHCARE HOLDINGS INC.
08/19Barclays Adjusts Price Target on Aveanna Healthcare Holdings to $5 From $7, Reiterates ..
MT
08/15Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $6 From $8, Reiter..
MT
08/12Deutsche Bank Adjusts Price Target on Aveanna Healthcare Holdings to $3 From $6, Mainta..
MT
08/11Aveanna Healthcare Seeks Tuck-In Acquisitions
CI
08/11Transcript : Aveanna Healthcare Holdings Inc., Q2 2022 Earnings Call, Aug 11,..
CI
08/11Aveanna Healthcare : ANNOUNCES SECOND-QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
08/11Aveanna Healthcare Holdings Inc. Reports Earnings Results for the Second Quarter and Si..
CI
08/11AVEANNA HEALTHCARE HOLDINGS, INC. Management's Discussion and Analysis of Financial Co..
AQ
08/11Aveanna Healthcare Holdings Inc. Reports Impairment Charges for the Three Months Ended ..
CI
08/11Aveanna Healthcare Holdings, Inc. : Results of Operations and Financial Condition, Regulat..
AQ
More news
Analyst Recommendations on AVEANNA HEALTHCARE HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2022 1 795 M - -
Net income 2022 -448 M - -
Net Debt 2022 1 181 M - -
P/E ratio 2022 -0,64x
Yield 2022 -
Capitalization 290 M 290 M -
EV / Sales 2022 0,82x
EV / Sales 2023 0,76x
Nbr of Employees 33 000
Free-Float 93,7%
Chart AVEANNA HEALTHCARE HOLDINGS INC.
Duration : Period :
Aveanna Healthcare Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVEANNA HEALTHCARE HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 1,56 $
Average target price 4,03 $
Spread / Average Target 158%
EPS Revisions
Managers and Directors
H. Anthony Strange Chief Executive Officer & Executive Director
David Afshar Chief Financial Officer
Rodney D. Windley Executive Chairman
Elizabeth A. Rubio Chief Clinical Officer
Jeffery Shaner Chief Operating Officer